Intel to use 'big data' to battle Parkinson's disease

August 13, 2014
Intel headquarters on January 16, 2014 in Santa Clara, California

US computing giant Intel announced Wednesday it was joining an effort to battle Parkinson's disease with new big data and wearable technologies to improve research and treatment.

Intel said it would work with the Michael J. Fox Foundation for Parkinson's Research—created by the "Back to the Future" Canadian-American actor—on the effort to fight the neurodegenerative brain disease second only to Alzheimer's in worldwide prevalence.

The research will use "a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms," an Intel statement said.

"This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in ."

The statement added that by collecting and analyzing data from thousands of individuals, such as slowness of movement, tremor and sleep quality, researchers can get a better picture of the progression of the disease.

The research will use wearables that "can unobtrusively gather and transmit objective, experiential data in real time, 24 hours a day, seven days a week," according to the statement.

"Nearly 200 years after Parkinson's disease was first described by Dr James Parkinson in 1817, we are still subjectively measuring Parkinson's disease largely the same way doctors did then," said Todd Sherer, chief executive of the foundation.

"Data science and hold the potential to transform our ability to capture and objectively measure patients' actual experience of disease, with unprecedented implications for Parkinson's drug development, diagnosis and treatment."

Explore further: Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients

Related Stories

Blood biomarker could mark severe cognitive decline, quicker progression among Parkinson's patients

September 18, 2013
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and ...

Anti-inflammatory drug can prevent neuron loss in Parkinson's model

July 25, 2014
An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson's disease, researchers at Emory University School of Medicine have shown.

First clinical data of therapeutic Parkinson's disease vaccine encourages continued development

August 1, 2014
AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is the first therapy against the protein alpha-synuclein, a promising ...

Researchers investigating genetics of Parkinson's disease

March 11, 2014
(Medical Xpress)—Researchers at Emory University School of Medicine will study individuals with genetic mutations associated with Parkinson's disease (PD) as part of the Parkinson's Progression Markers Initiative (PPMI), ...

Depression a key factor in health of Parkinson's patients: study

November 28, 2012
(HealthDay)—Depression is the most important determinant of the health status of people with Parkinson's disease, according to early findings from a large study of Parkinson's patients.

Intel buys fitness-tracking band maker Basis (Update)

March 25, 2014
Intel announced it has bought fitness-tracking band maker Basis Science as part of a move into the hot wearable computing market.

Recommended for you

Parkinson's disease 'jerking' side effect detected by algorithm

January 8, 2018
A mathematical algorithm that can reliably detect dyskinesia, the side effect from Parkinson's treatment that causes involuntary jerking movements and muscle spasms, could hold the key to improving treatment and for patients ...

New brainstem changes identified in Parkinson's disease

January 4, 2018
A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Researchers shed light on why exercise slows progression of Parkinson's disease

December 22, 2017
While vigorous exercise on a treadmill has been shown to slow the progression of Parkinson's disease in patients, the molecular reasons behind it have remained a mystery.

Robotic device improves balance and gait in Parkinson's disease patients

December 19, 2017
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years ...

New findings point to potential therapy for Parkinson's Disease

December 19, 2017
A new study, published in Proceedings of the National Academy of Sciences (PNAS), sheds light on a mechanism underlying Parkinson's disease and suggests that Tacrolimus—an existing drug that targets the toxic protein interaction ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.